Explore more publications!

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on September 22, 2025

APA Statement on White House Announcement on Autism
AMN Healthcare Announces Pricing of Senior Notes Offering
Fortrea Appoints William Sharbaugh to Board of Directors
BetaGlue Therapeutics gibt die Ernennung von Alexis Peyroles zum neuen Chief Executive Officer bekannt
BetaGlue Therapeutics annonce la nomination d’Alexis Peyroles au poste de directeur général
MBX Biosciences Announces Proposed Public Offering
GENFIT Reports First-Half 2025 Financial Results and  Provides Corporate Update
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
Until Labs Announces $58M Series A Funding Round, to Develop an Organ Cryopreservation Product for Transplant Patients and Surgeons
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination
The Sentinel Introduces Transformative Approach to Healing in British Columbia, Setting a New Standard in Integrative Care
MEDIA ADVISORY - Protests Against Ford Government’s Expanding Hospital Privatization Plans
Employers prepare for disruptive and transformative health plan changes, WTW survey finds
API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs
Thalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight
Fairhaven Health Develops Clinical Nutrition-Based Formulas to Support Women with PCOS and PMS

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions